https://www.aacr.org/blog/2023/11/21/pancreatic-cancer-research-driven-clinical-progress-examined-at-aacr-special-conference/
Pancreatic Cancer: Research-driven Clinical Progress Examined at AACR Special Conference - American...
Dec 1, 2023 - Researchers at the 2023 AACR Special Conference on Pancreatic Cancer presented new ways to improve outcomes for patients.
pancreatic cancer researchclinical progress
https://investingnews.com/psychedelics-policy-clinical-progress/new-psychedelics-laws-and-research-initiatives
US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025 | INN
May 14, 2025 - Apart from Oregon and Colorado, a wave of legislative activity concerning psychedelics is evident across the US, with states like Illinois, Indiana, Missouri,...
us policyclinical progressmomentum
https://pmc.ncbi.nlm.nih.gov/articles/PMC12730407/
Oncolytic Viruses in Glioblastoma: Clinical Progress, Mechanistic Insights, and Future Therapeutic...
Glioblastoma (GBM) is the most aggressive primary brain tumor, with limited treatment options and a poor median survival of around 15 months. Oncolytic viruses...
oncolytic virusesclinical progressglioblastoma
https://www.sintef.no/en/publications/publication/1131476/
Designing privacy-friendly digital whiteboards for mediation of clinical progress - SINTEF
digital whiteboardsclinical progressdesigningprivacyfriendly
https://investingnews.com/psychedelics-policy-clinical-progress/investor-takeaway
US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025 | INN
May 14, 2025 - Against this backdrop, the psychedelics market could see promising growth in 2025. While challenges remain, the expansion of legalization and...
us policyclinical progressmomentum
https://investingnews.com/psychedelics-policy-clinical-progress/legal-state-psychedelics-markets-take-shape
US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025 | INN
May 14, 2025 - Psychedelic compounds remain federally illegal in the US, but some states have pursued legalization and decriminalization. In November 2020, Oregon became the...
us policyclinical progressmomentum
https://www.jci.org/articles/view/40553/pdf
JCI - Progress toward the clinical application of patient-specific pluripotent stem cells
clinical application
https://progressclinicalresearch.nl/
Progress Clinical Research - Home
Apr 24, 2026 - Bij Progress Clinical Research pionieren we al 15 jaar in medisch onderzoek met drie geavanceerde faciliteiten in Nederland. We ontwikkelen nieuwe medicijnen...
clinical researchprogress
https://finviz.com/news/338704/igc-pharma-reports-financial-results-and-clinical-progress-for-the-period-ended-december-31-2025
IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025
Stock screener for investors and traders, financial visualizations.
https://www.biospace.com/selection-inc-to-present-update-on-clinical-progress-at-the-42nd-annual-j-p-morgan-healthcare-conference-in-san-francisco-ca-on-january-11-2024
selectION, Inc. to Present Update on Clinical Progress at the 42nd Annual J.P. Morgan Healthcare...
Jan 5, 2024 - selectION, Inc. announced that management will present at the 42nd Annual J.P. Morgan Healthcare Conference.
https://www.news-medical.net/news/20260504/Disruptions-threaten-progress-in-inclusive-clinical-trials-and-health-equity.aspx
Disruptions threaten progress in inclusive clinical trials and health equity
May 5, 2026 - JMIR Publications today featured a critical new story in its News and Perspectives section examining the recent waves of disruption to inclusive clinical...
clinical trialsdisruptionsthreatenprogressinclusive
https://www.newswire.com/news/ascendiant-capital-markets-raises-igc-pharma-price-target-to-5-25-citing
Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and...
https://www.businesswire.com/news/home/20241126520530/en/Delta-Fly-Pharma-Inc.-Progress-Update-of-the-Phase-III-Clinical-Trial-of-DFP-14323
Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323
We are excited to share our latest development status. Similar to its position in the United States, we are pleased to announce that Afatinib, which is being...
phase iii clinical trial
https://pmc.ncbi.nlm.nih.gov/articles/PMC5849079/
Vascular tissue engineering: progress, challenges, and clinical promise - PMC
Although the clinical demand for bioengineered blood vessels continues to rise, current options for vascular conduits remain limited. The synergistic...
vascular tissueengineeringprogresschallengesclinical
https://www.gsk.com/en-gb/media/press-releases/gsk-showcases-progress-from-the-dreamm-clinical-trial-programme-in-multiple-myeloma-at-the-2021-ash-annual-meeting/
GSK showcases progress from the DREAMM clinical trial programme in multiple myeloma at the 2021 ASH...
11 abstracts on Blenrep will be presented at the upcoming American Society of Hematology (ASH) Annual Meeting and Exposition.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.655063/full
Frontiers | Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional...
Background: The outbreak of new coronavirus has tremendously threatened the public health system worldwide, including China. Chinese patent medicines (CPMs) ...